| Dr Win Kyaw, MD, | |
|
172 Kinsley St, Nashua, NH 03060-3648 | |
| (603) 882-3000 | |
| Not Available |
| Full Name | Dr Win Kyaw |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 172 Kinsley St, Nashua, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073848982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 14463 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Nashua, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Apogee Medical Group New Hampshire Pc | 4688021983 | 17 |
| Nes Medical Services Of New England Inc | 6204229669 | 45 |
News Archive
"The Pan American Health Organization (PAHO) strongly disagrees with the allegations in the recent Reuters article that the food and beverage industry advises our policymaking" with respect to non-communicable diseases (NCDs), the agency said in a press release on Saturday.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
Joan M. O'Brien, MD, the George E. de Schweinitz and William F. Norris Professor of Ophthalmology, chair of the Department of Ophthalmology and director of the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania, was recently presented with the Women in Ophthalmology's Suzanne Veronneau Troutman Award.
When tendon trouble - such as tennis elbow or Achilles tendon pain - doesn't respond to traditional treatment, an injection of the patient's own blood plasma into the tendon may provide relief.
A new computer program could help doctors predict which patients might suffer potentially fatal side-effects from a key stroke treatment.
› Verified 7 days ago
| Entity Name | Maine Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053878371 PECOS PAC ID: 3375884216 Enrollment ID: O20201028002959 |
News Archive
"The Pan American Health Organization (PAHO) strongly disagrees with the allegations in the recent Reuters article that the food and beverage industry advises our policymaking" with respect to non-communicable diseases (NCDs), the agency said in a press release on Saturday.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
Joan M. O'Brien, MD, the George E. de Schweinitz and William F. Norris Professor of Ophthalmology, chair of the Department of Ophthalmology and director of the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania, was recently presented with the Women in Ophthalmology's Suzanne Veronneau Troutman Award.
When tendon trouble - such as tennis elbow or Achilles tendon pain - doesn't respond to traditional treatment, an injection of the patient's own blood plasma into the tendon may provide relief.
A new computer program could help doctors predict which patients might suffer potentially fatal side-effects from a key stroke treatment.
› Verified 7 days ago
| Entity Name | Nes Medical Services Of New England Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396401907 PECOS PAC ID: 6204229669 Enrollment ID: O20220207001753 |
News Archive
"The Pan American Health Organization (PAHO) strongly disagrees with the allegations in the recent Reuters article that the food and beverage industry advises our policymaking" with respect to non-communicable diseases (NCDs), the agency said in a press release on Saturday.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
Joan M. O'Brien, MD, the George E. de Schweinitz and William F. Norris Professor of Ophthalmology, chair of the Department of Ophthalmology and director of the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania, was recently presented with the Women in Ophthalmology's Suzanne Veronneau Troutman Award.
When tendon trouble - such as tennis elbow or Achilles tendon pain - doesn't respond to traditional treatment, an injection of the patient's own blood plasma into the tendon may provide relief.
A new computer program could help doctors predict which patients might suffer potentially fatal side-effects from a key stroke treatment.
› Verified 7 days ago
| Entity Name | Apogee Medical Group New Hampshire Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154102242 PECOS PAC ID: 4688021983 Enrollment ID: O20231108001223 |
News Archive
"The Pan American Health Organization (PAHO) strongly disagrees with the allegations in the recent Reuters article that the food and beverage industry advises our policymaking" with respect to non-communicable diseases (NCDs), the agency said in a press release on Saturday.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
Joan M. O'Brien, MD, the George E. de Schweinitz and William F. Norris Professor of Ophthalmology, chair of the Department of Ophthalmology and director of the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania, was recently presented with the Women in Ophthalmology's Suzanne Veronneau Troutman Award.
When tendon trouble - such as tennis elbow or Achilles tendon pain - doesn't respond to traditional treatment, an injection of the patient's own blood plasma into the tendon may provide relief.
A new computer program could help doctors predict which patients might suffer potentially fatal side-effects from a key stroke treatment.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Win Kyaw, MD, 26 Kessler Farm Dr, Apt 429, Nashua, NH 03063-7133 Ph: (646) 709-5590 | Dr Win Kyaw, MD, 172 Kinsley St, Nashua, NH 03060-3648 Ph: (603) 882-3000 |
News Archive
"The Pan American Health Organization (PAHO) strongly disagrees with the allegations in the recent Reuters article that the food and beverage industry advises our policymaking" with respect to non-communicable diseases (NCDs), the agency said in a press release on Saturday.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
Joan M. O'Brien, MD, the George E. de Schweinitz and William F. Norris Professor of Ophthalmology, chair of the Department of Ophthalmology and director of the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania, was recently presented with the Women in Ophthalmology's Suzanne Veronneau Troutman Award.
When tendon trouble - such as tennis elbow or Achilles tendon pain - doesn't respond to traditional treatment, an injection of the patient's own blood plasma into the tendon may provide relief.
A new computer program could help doctors predict which patients might suffer potentially fatal side-effects from a key stroke treatment.
› Verified 7 days ago
Christopher Michael Riccio, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17 Prospect St, Nashua, NH 03060 Phone: 603-594-6337 Fax: 603-594-6330 | |
Dr. Mark Liebling, Internal Medicine Medicare: Medicare Enrolled Practice Location: 166 Kinsley St Ste 301, Nashua, NH 03060 Phone: 603-883-5673 Fax: 603-689-1343 | |
Dr. Chengta Richard Dai, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 168 Kinsley Street, Suite 20, Nashua, NH 03060 Phone: 603-578-9363 Fax: 603-578-9539 | |
Dr. William Stephan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 168 Kinsley St, Nashua, NH 03060 Phone: 603-889-4131 | |
Ihab M Ziada, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 173 Daniel Webster Hwy, Nashua, NH 03060 Phone: 603-891-4500 | |
Ajay K Sharma, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2039 Fax: 603-882-5656 | |
Dr. Gianfranco Tulliano, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2045 Fax: 603-577-5644 |